Why the study?
Periprocedural myocardial injury predicts cardiovascular morbidity and mortality after PCI, prompting evaluation of the effects of preprocedural lipid levels.
Do preprocedural lipid levels predict periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention?
Do preprocedural lipid levels predict periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention?
In patients with stable coronary artery disease undergoing elective percutaneous coronary intervention, preprocedural lipid levels were not associated with periprocedural myocardial injury, likely due to high rates of baseline statin therapy and well-controlled LDL.
Answers are grounded in this paper and cite their sources.
Preprocedural lipids should not guide periprocedural injury risk assessment in elective PCI; leaves open effects in statin-naive or higher-risk cohorts.
BACKGROUND: Periprocedural myocardial injury is a predictor of cardiovascular morbidity and mortality after percutaneous coronary intervention. METHODS: The authors examined the effects of preprocedural lipid levels (low-density lipoprotein, high-density lipoprotein, and triglycerides) in 977 patients with coronary artery disease who underwent elective percutaneous coronary intervention. RESULTS: Elevated cardiac troponin I level (≥5× the upper limit of normal) was used to indicate periprocedural myocardial injury. Serum lipid samples were collected 12 hours preprocedurally. Cardiac troponin I was collected 1, 6, and 12 hours postprocedurally. Correlations between preprocedural lipid levels and postprocedural cardiac troponin I were studied. Low-density lipoprotein levels were less than 70 mg/dL in 70% of patients and greater than 100 mg/dL in only 7.4% of patients; 13% had triglyceride levels greater than or equal to 150 mg/dL, and 96% had high-density lipoprotein levels less than 40 mg/dL. Patients with elevated cardiac troponin I had significantly lower left ventricular ejection fraction than did those with cardiac troponin I levels less than 5× the upper limit of normal (P = .01). Double-and triple-vessel disease were more common in patients with elevated cardiac troponin I (P < .002). Multivariable logistic and linear regression analyses revealed no statistically significant associations between lipid levels and postprocedural cardiac troponin I elevation, possibly because such large proportions of included patients had low levels of low-density lipoprotein (70%) and a history of statin intake (86%). CONCLUSION: The authors found no association between lipid profile and periprocedural myocardial injury.
No takes yet. Share an insight, caveat, or question.
Maadani et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: